Average Co-Inventor Count = 2.37
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roche Glycart Ag (10 from 68 patents)
2. Glycart Biotechnology Ag (4 from 7 patents)
3. Roche Glyeart Ag (1 from 3 patents)
15 patents:
1. 9957326 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
2. 9309317 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
3. 9296820 - Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function
4. 9074008 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
5. 9068008 - Antibodies to carcinoembryonic antigen (CEA), methods of making same, and uses thereof
6. 8945571 - Targeted immunoconjugates
7. 8883980 - Antigen binding molecules with increased Fc receptor binding affinity and effector function
8. 8614065 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
9. 8273328 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
10. 8097436 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
11. 8088380 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
12. 7846432 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
13. 7727741 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
14. 7722867 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
15. 7662377 - Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof